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ABSTRACT
Therapeutic and prophylactic inferior vena cava (IVC) filters should be placed
based on currently accepted indications to prevent a fatal pulmonary embolism (PE). The
protective effect of filters is offset by the potential for lower extremity deep venous
thrombosis (DVT), caval thrombosis, and possible otherwise unnecessary life-long anti-
coagulation (AC). The duration of treatment for most DVTs or PEs is 3 to 6 months of
AC/filter. Filters should be retrieved when duration of treatment for a DVT/PE has been
met, the risk of a PE is no longer high, and/or there is no longer a contraindication to AC.
An effective system that leads to improving the retrieval rate of filters must include
education of the patient, a tracking system to minimize patient lost to follow-up, and
dedicated personnel to oversee the process. If these goals are accomplished, intervention-
alists can help decrease the incidence of a fatal PE during the high-risk period, and also
decrease the risk of a DVT or the use of otherwise unnecessary life-long AC in subsequent
years. Currently, there is much room for improvement in the frequency that IVCF patients
are systematically followed and filters are retrieved. The principles discussed in this report
will be helpful in this process.
KEYWORDS: Retrievable inferior vena cava filters, tracking inferior vena cava filter
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CLINICAL VIGNETTE
A 23-year-old man was involved in a motor vehicle
collision, and suffered multiple trauma including a severe
closed head injury as well as complex pelvic and bilateral
femur fractures. He remained comatose following a
decompressive craniotomy for an expanding intracranial
hemorrhage. The interventional radiology (IR) service
was asked to place a prophylactic retrievable inferior vena
cava filter because the patient was immobilized, was felt
to be at high risk from a pulmonary embolism (PE), and
could not be placed on low-dose heparin for prophylaxis
against a deep venous thrombosis (DVT). The indica-
tions, conduct, and possible outcomes of the procedure
(including the possible inability to retrieve the filter)
were discussed with his wife who provided consent. A
retrievable inferior vena cava filter (IVCF) was inserted
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on hospital day 2. The patient recovered from his
injuries, and was transferred to a rehabilitation facility
one month later. He continued to make gradual prog-
ress, and 6 months later he was able to ambulate well
with a cane. He returns to the IR clinic stating that since
he is at risk for developing a DVT because of the filter,
his primary care provider plans to initiate lifelong anti-
coagulation (AC) with Coumadin. He mentions that he
heard about a recent (August 9, 2010) U.S. Food &
Drug Administration (FDA) communication regarding
IVC filters. He asks for your opinion regarding the safety
and effectiveness of IVCF, and more importantly, how
to proceed at this time.
THE PROBLEM
This is a former multitrauma patient who was at high
risk for a DVT and PE in the immediate postinjury
period and had a prophylactic retrievable inferior vena
cava filter (PIVCF) inserted but was lost to follow-up.
He now returns with the filter that is no longer necessary
but is still in place. His primary care provider plans to
start AC. What is the best course of action at this time
given this clinical scenario?
DISCUSSION
Trauma patients are at risk for a DVT and PE; PE causes
5% of deaths in the trauma patient who is hospitalized
more than 48 hours.1 The prophylactic insertion of a
retrievable IVCF to decrease the incidence of a fatal PE
in the high-risk trauma patient has gained increasing
popularity over the last two decades.1,2 In addition to the
standard indications for an IVCF, indications for the use
of a PIVCF have been established. The Eastern Associ-
ation for the Surgery of Trauma (EAST) has published a
clinical practice guideline that focuses on decreasing the
incidence of venous thromboembolism (VTE) in high-
risk trauma patients (http://www.slrsurgery.org/files/
guidelines/Traum_DVT_study_J_of_T_2007.pdf).3 In-
sertion of a PIVCF should be considered in trauma
patients who cannot receive anticoagulation because of
an increased bleeding risk, and have an injury pattern
rendering them immobilized for a prolonged period.
Appropriate PIVCF patients include those with (1)
severe closed head injury (Glasgow Coma Scale score of
eight or less), (2) spinal cord injury with paraplegia or
quadriplegia, (3) complex pelvic fractures with associated
long bone fractures, and (4) multiple long bone fractures
(Fig. 1).3
Prospective venographic studies of trauma pa-
tients reveal that venous thromboembolism (i.e., DVT
and PE) is common in these patients. VTE is estimated
to be the third most common cause of in-hospital deaths
in trauma patients.4 Geerts et al documented that 201
(58%) of 349 trauma patients developed DVT, with
proximal DVT occurring in 63 (18%) of patients.5
Note that in this study no VTE prophylaxis was used,
and only 3 of the 201 patients with DVT had clinical
signs of the DVT. Seven (2%) of the patients had PE
and in three of these the PE was fatal. The instances of
DVT and PE are estimated to be even higher in the
polytraumatized patients categorized in the EAST
guideline. Operators placing filters should be familiar
with the EAST indications for a PIVCF and their own
local practice patterns or protocols, as well as have a
system for tracking these patients so that each device can
be removed when it is no longer needed. Failure to do so
will result in many patients harboring a subsequently
unnecessary IVCF when the benefit-to-risk ratio is no
longer favorable.
The PRECIP trial performed by Decousus et al
demonstrated that patients with IVC filters are at
increased risk of developing a recurrent lower extremity
DVT and/or clot within the filter (Table 1).6 This
randomized prospective study was designed to evaluate
Figure 1 EAST Guidelines for a prophylactic inferior vena cava filter.
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the safety and effectiveness of permanent IVCF for
general surgical and medical patients. Four-hundred
patients with proximal DVT who were believed to be
at high risk for PE were randomized to either receive AC
plus an IVC filter (‘‘filter group’’) versus AC alone (‘‘no
filter group’’). They initially studied patients at 12 days
following randomization for both symptomatic and
asymptomatic PE, and at 2 years for symptomatic
VTE. The authors concluded that in high-risk patients
with proximal DVT, the initial benefit of IVCF for
prevention of PE was counterbalanced by an excess of
recurrent DVT, without any difference in mortality.
Closer examination of the table reveals that although
the rate of recurrent PE was not statistically different, if
the authors had compared the rate of fatal PE it is
possible to demonstrate the beneficial effect of filters at
2 years as well. The PREPIC (Prevention du Risque
d’Embolie Pulmonaire par Interruption Cave) data has
been extended for an 8-year follow-up demonstrating
that a patient with a filter is significantly more likely to
subsequently develop a recurrent lower extremity DVT
compared with a patient without a filter (36% vs 28%
over an 8-year follow-up, P¼ .042), albeit with a lower
risk of developing a PE (6.2% vs 15.1%, P¼ 0.54). The
combined rate of symptomatic DVT and PE at 8 years
was nearly identical in the two groups.7
All these data suggest that filters are effective in
preventing fatal and nonfatal PE. After 8 years of study,
the number of patients with lower extremity DVT in the
filter group compared with the no filter group was 55
versus 41. This was not statistically significant. The
number of patients with IVC thrombosis in the filter
group compared with the no filter group was 26 versus 2
(19 patients in the no filter group crossed over and ended
up with a filter and 2 of these patients experienced IVC
thrombosis by 8 years). The number of patients with
symptomatic PE in the filter group versus no filter group
was 9 versus 24. Because many PEs are asymptomatic, if
the ratio of PE between the two groups is the same for
asymptomatic and for symptomatic, the decreased num-
ber of total PE is very similar to the increased number of
IVC thrombosis in the filter group. The emphasis of the
findings from the Decousus et al study should be that
filters work, rather than that filters are thrombogenic.
Decousus et al concluded that at 8 years, IVCF
reduced the risk of a PE but increased the risk of a DVT
and had no effect on survival. The authors did NOT
conclude that the mere presence of a filter mandates AC
if it is subsequently no longer contraindicated. Although
an alternative explanation of the same data are that
IVCF reduced the ongoing risk of PE by effectively
catching clot in the filter, the results of the Prevention du
Risque d’Embolie Pulmonaire par Interruption Cave
(PREPIC) trial have led many clinicians to consider
placing a patient with an IVCF on lifelong AC to
decrease the likelihood of developing a lower extremity
DVT or IVC thrombosis.8 It is possible, therefore, that a
trauma patient with no history of a DVT or PE, who
undergoes insertion of a PIVCF that subsequently is not
removed, may ironically end up on lifelong AC. The
downside is that AC is associated with well-known
complications, to include bleeding, requirement for
blood transfusions, and even death. The incidence of
significant hemorrhage is estimated at 5% per year of
lifelong AC.9 It is possible that the risk of harm to a
patient is greater from the AC than from the filter.
Ray et al did a meta-analysis to study whether
anticoagulation affects VTE rates in patients with fil-
Table 1 PREPIC Study: Clinical Results of Trial after 12 Days, 2 and 8 Years
Results @ 12 days Symptomatic and
Asymptomatic Patients
AC & IVCF ‘‘Filter
Group’’ (n¼ 200)
AC Alone ‘‘No Filter
Group’’ (n¼ 200) Statistics
Recurrent PE 2(1.1%) 9(4.8%) P¼ .03
Recurrent PEs in patients presenting with PEs (1.1%) (8.6%)
Mortality 5 (2.5%) 5 (2.5%) P¼ .99
Results @ 2 yearsSymptomatic Patients Only
Recurrent PEs 6 (3.4%)-1 fatal 12(6.3%)-5 fatal P¼ .16
Recurrent DVTs 37 (20.8%) 21 (11.6%) P¼ .02
IVC filter thromboses (Subset of recurrent DVTs) 16 (9%)
Major bleeding 17 (8.8%) 22 (11.8%)
Mortality 43 (21.6%) 40 (20.1%) P¼ .65
Results @ 8 years Symptomatic Patients Only
Recurrent PEs 9 (6.2%)-2 fatal 24(15,1%)-5 fatal P¼ .008
Recurrent DVTs 57 (35.7%) 41 (27.5%) P¼ .042
IVC filter thromboses (Subset of recurrent DVTs) 26 (16%) 2* (1.3%)
Major bleeding 26 (15.4%) 31 (18.5%)
Mortality 98 (48.1%) 103 (61.0%) P¼ .83
*19 of the 200 patients in the AC alone cohort (‘‘no filter group’’) subsequently underwent filter insertion during the study period.
AC, anticoagulation; DVT, deep venous thrombosis; IVCF, inferior vena cava filter; PE, pulmonary embolism; PREPIC, Prevention du Risque
d’Embolie Pulmonaire par Interruption Cave
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ters.10 This was a systemic review of the literature from
1963 to 2007, which included reports where (1) there
was a clear identification if AC was used in a filter
patient; (2) short- or long-term VTE outcomes were
presented; (3) outcomes were specifically addressed after
filter placement with and without AC; and (4) the trial
was a randomized controlled, prospective cohort, retro-
spective cohort, or case-controlled study. One hundred
thirty-five references were found and reviewed, with only
nine total studies meeting inclusion criteria. Among the
1369 subjects included in the analysis, the VTE rate was
12.3% with IVCF plus AC versus 15.8% with IVCF but
no AC (OR, 0.64%, 95% CI, 0.35–1.16, P¼ .14). The
authors concluded that IVCF can be placed in patients
who cannot receive concomitant AC without placing
them at significantly higher risk of development of VTE.
Despite this study, the role for AC following a filter
insertion beyond the treatment period for a DVT/PE
remains controversial. Therefore, to avoid the potential
increased risks of VTE and lifelong AC in patients with
filters, retrievable IVCF should be removed when the
risk of a PE is no longer high and/or there is no
contraindication to AC. This is important to do not
only for devices that are implanted for standard ther-
apeutic indications, but even more so for devices inserted
for prophylaxis against fatal PE in the high-risk multi-
trauma patient.
The frequency of PIVCF removal has tradition-
ally been very low; at the same time their use has
increased.1,2 Several recent reports demonstrate that
the technical success rate of most filter retrieval is very
high (range from 58–100% with mean of 93%) further
exemplifying the importance of following up such
patients.11 It has also been shown when patients are
followed very closely, it is possible to eventually retrieve
as many as 50% or more of the filters that are in-
serted.12–14 This very respectable retrieval rate, how-
ever, usually occurs only under study conditions. For
most IR practices, particularly those that are not in-
volved in clinical research on IVCF, the actual percent-
age of filters that are retrieved is much lower, and often
may be less than 10%. Given the potential long-term
consequences of an IVCF (i.e., DVT, caval thrombosis,
possible otherwise unnecessary lifelong AC, filter mi-
gration or fracture), it is imperative that systems
are established to improve education, track, and even-
tually remove each device when it is no longer needed.
In 2006, the Society of Interventional Radiology pub-
lished an excellent set of guidelines for the use of
retrievable IVCF, which include both indications
(presently the same as permanent filters) and algo-
rithms for removal of retrievable IVCF (http://
www.sirweb.org/misc/Guidelines_filters.pdf).15 Oper-
ators placing filters who insert and retrieve IVCF
should be familiar with the contents of this useful
document.
On August 9, 2010, the FDA issued the following
communication: ‘‘FDA recommends that implanting
physicians and clinicians responsible for the ongoing
care of patients with retrievable IVC filters consider
removing the filter as soon as protection from PE is no
longer needed.’’16 In this communication, it was reported
that since 2005 the FDA has received 921 adverse events
involving IVCF on their MAUDE database (www.ac-
cessdata.fda.gov). This database relies on individual
physicians to report problems with filters so there is an
inherent bias with possible underreporting. Within this
database, there were 328 reported instances of device
migration, 146 instances of device embolizations (de-
tachment of filter components), 70 instances of perfo-
ration of the IVC, and 56 instances of filter fracture.
Although 921 adverse events seems significant, the
reader must be cognizant of the many tens (or even
hundreds) of thousands of these filters that have been
placed during this timeframe. Some of the reported
events occurred in patients who had clinically significant
adverse outcomes. SIR has responded with the following
statement: ‘‘The Society of Interventional Radiology
strongly urges close communications between doctor
and patient. Those individuals with IVC filters are
encouraged to talk to their interventional radiologists
and their other physicians about any concerns or ques-
tions. Patients with filters should always discuss with
their doctors whether and when filter removal is an
option.’’17 Both the FDA and SIR statements emphasize
the need for filter patients to undergo retrieval of their
IVCF as soon as ‘‘protection from PE is no longer
needed,’’ suggesting that patients need to be followed
closely and brought back for IVCF removal at the
appropriate time.
To determine the optimal time for retrieval of the
IVCF, it is important to be familiar with the guidelines
for the treatment of DVT and PE in general. Current
guidelines were published in 2008 by the American
College of Chest Physicians (http://chestjournal.chest-
pubs.org/content/133/6_suppl/454S.full.pdfþ html).18
For anyone with a single episode of DVT or PE, the
treatment includes AC for 3 or 6 months depending on
the clinical scenario and the discretion of the treating
physician. When the patient cannot be placed on AC, an
IVCF is inserted and the duration of the treatment for
protection from PE should still be a total of 3 or
6 months; this includes filter indwell time and anti-
coagulation time if the filter has already been removed.
For this reason, patients with an IVCF can often have
the filter removed after 3 or 6 months have elapsed since
their index event. This fact can be very helpful in
determining the timing for removal of an IVCF.
In the event that a patient who temporarily
cannot receive AC undergoes a filter insertion, and later
is able to start AC, it is important to initiate AC while
the filter is still in place.15,17 It is also reasonable at that
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time to consider retrieval of the filter after the patient is
therapeutic on AC to decrease the likelihood of filter
complications. As suggested in the 2006 SIR guideline,
it is neither necessary nor desirable to interrupt AC for
the retrieval. Therapeutic AC does not increase the risk
of bleeding complications from filter retrieval.18,19 In
one study, 62 IVCF removals were attempted in anti-
coagulated patients. There was no extravasation seen on
cavography after filter removal, and no operative bleed-
ing complications, hematomas, or contusions. Use of
ultrasound to guide the puncture at the access site should
minimize potential bleeding complications. Once the
filter is retrieved, the patient can complete the 3- or 6-
month course of treatment for the DVT or PE. In the
event a patient remains unable to start AC, the filter
should be left in place until the 3- or 6-month duration
of treatment is completed. The filter should be removed
when either the 3- or 6-month mark is reached, assum-
ing the indication for filter placement no longer exists.
One additional caveat should be considered in those
patients in whom a prophylactic filter was placed. Be-
cause there was no known DVT or PE at the time of
insertion, the timing of filter removal may be based on
when the patient is either ambulating well or when he or
she has reached a level of stability and no additional
surgical procedure is planned. Prior to filter removal in
these patients, based on local practice, ultrasound screen-
ing of the lower extremities may be performed to make
sure that the patient has not developed a DVT during
the period of immobility and illness.
A COMPREHENSIVE METHOD TO
INCREASE IVC FILTER RETRIEVALS
To achieve the ultimate goal of retrieval of an IVCF that
is no longer needed, an effective system must be estab-
lished to facilitate the entire process. A successful re-
trieval system should have three essential components.
These include (1) the education of health care providers,
patients, and their families; (2) a method of tracking
filter patients; and (3), an individual who is dedicated
and responsible for the success of the entire process.
Establishing only one or two of these processes is not
sufficient, and many patients will become lost to follow
up. However, if all three key components are effectively
implemented, the goal of increasing filter retrieval will
most likely be achieved.
Education
The patient, immediate family, and any significant
friend should be thoroughly educated regarding the
indications for filter insertion as well as the indications
for filter retrieval. The key to adult learning is repetition;
therefore, the process of obtaining informed consent and
thoroughly familiarizing the patient and others regard-
ing the entire process from start to finish will usually
require several encounters. It begins with the initial
preprocedure evaluation, is continued during the imme-
diate periprocedure period, and should be reinforced
during the week or so following filter insertion. When-
ever possible, it is important to conduct another visit
prior to the patient’s discharge or transfer to another
facility if the filter has not yet been removed to provide
additional reinforcement. These visits can be performed
by an IR physician, an IR nurse, trauma nurse, or any
qualified individual (e.g., radiology practitioner assistant
[RPA] or other midlevel provider) who has been appro-
priately trained. During each encounter, the patient and
family should be given an opportunity to ask questions
and receive information that can reinforce their under-
standing of the importance of follow-up and possible
retrieval of the filter when it is no longer needed. It is
important to ensure that both the patient and family
know how to contact the tracking service once they leave
the hospital. A successful retrieval system includes a
patient who understands the importance of retrieval of
an unnecessary filter. An informed family will also help
increase the likelihood that appropriate follow-up is
accomplished and the filter patient is not lost to fol-
low-up.
Informational handouts that the patient and fam-
ily can take with them on discharge from the hospital
will go a long way to facilitate successful education.
Manufacturers of IVCF often provide a patient booklet
with each filter, which should be utilized whenever
possible. Alternatively, sketches and diagrams that can
be downloaded from the Internet allow for a better
understanding of the basic processes of insertion and
retrieval of the filter. Descriptions of the benefits and
risks of an IVCF (both in the short- and long-term) will
help to ensure that these important facts are discussed.
The potential retrievability of various filters can be
illustrated and the importance of appropriate follow-up
and possible filter removal can be emphasized.
The education piece of any successful system also
involves familiarizing other health care providers, in-
cluding physicians, nurses, and therapists, about the
importance of filter retrieval when it is no longer useful.
Many health care workers today are not aware that it is
possible to retrieve some IVCF. Many are also not aware
of the potential long-term consequences of keeping a
filter in place when it is no longer necessary, and are not
likely to refer a patient for filter retrieval. It is especially
important that primary care providers and any physician
involved in the care of a filter patient understand the
importance of filter retrieval. Nursing personnel as well
as therapists can also play a role in identifying patients
who should have a filter retrieved. If other members of
the health care team are well informed, a filter patient is
less likely to become lost in the system and not be
referred back for filter retrieval.
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Tracking System
A system must be established that will allow the accurate
tracking of all patients with retrievable filters. In this
manner, the clinical course of each patient can be closely
followed, and appropriate follow-up and retrieval of an
unnecessary filter be performed. This system can be as
simple as an Excel spreadsheet with basic patient dem-
ographics, details of indications for insertion, and po-
tential date of retrieval (Fig. 2). It is very important to
obtain two or more phone numbers that can be used to
contact the patient in the future. A specific individual
should be assigned to manage the database to ensure
timely and accurate entries during the entire spectrum of
care, beginning with filter insertion and extending be-
yond filter retrieval (discussed below). A computerized
medical record system will facilitate evaluation of the
progress of the patient following filter insertion. Good
communication between the service that is tracking the
patient and individuals primarily responsible for the care
of the patient will further the decision regarding the
optimal timing for filter retrieval.
Some hospitals use techniques to identify patients
with retrievable IVCF such as armbands and reminders
in the medical records that denote the patient has a
retrievable filter. This facilitates the dissemination of
information when multiple teams of providers are caring
for the patient or when a patient is transferred to another
facility. The increasing availability of electronic medical
records may help in the education of medical staff by
sending alerts in both the inpatient and outpatient charts
indicating the time since filter placement and informa-
tion on how to schedule the patient for removal.
Although other tools can be used by patients to
remind them of the indwelling filter and the potential for
Figure 2 A simple spreadsheet used to track filter patients.
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removal, nothing should attempt to replace consistent
communication between the patient and family and the
service that is tracking the patient. Only by identifying
whether the indication for the filter still exists can one
determine the appropriateness of filter retrieval; no other
tool can replace the need for this constant communica-
tion. In this regard, the business card and dedicated
personnel (discussed below) have proven to be invaluable
assets.
At the time of the filter insertion, it is helpful to
arrange for an appointment in the IR clinic or for a
follow-up telephone call in 4 weeks. This will help to
ensure that a future evaluation of the patient’s progress is
made. Decisions regarding management of the filter can
be made during that follow-up encounter. Occasionally,
in patients with a very clear window of need for the filter,
it is possible to set up their appointment for filter
retrieval before they leave the IR suite following filter
placement. These patients should all receive a standard
reminder call from the clerical staff the day before their
next appointment. This can help to decrease the ‘‘no-
show’’ rate.
Dedicated and Responsible Personnel
The most important aspect of a successful filter removal
program is having dedicated personnel assigned to en-
sure the success of the entire process. A physician,
physician assistant, nurse, or clerk who is charged with
the responsibility of notifying providers and patients
when a filter may be removed is very important. Standard
letters, telephone calls, and reminders in the electronic
medical records need to be available and utilized, but
individual attention is necessary for all of these adjuncts
to work. This responsible individual must be self-moti-
vated, thorough, and committed to the task.
A policy of dedicated follow-up within a system
designed to track and retrieve IVCF spearheaded by a
nurse practitioner (NP) can achieve a high rate of filter
removal. O’Keeffe et al studied trauma and nontrauma
patients who had a retrievable IVCF placed at Parkland
Medical Center in Dallas, Texas, in 2006.20 This level
one trauma center has three separate trauma services, and
a NP is an integral member of each service. In 2005, the
removal rate of retrievable filters was 13%, and a dedi-
cated tracking system was not in place. The study was
conducted between January 1 and December 31, 2006.
During this period, a tracking protocol for trauma
patients was utilized consisting of chart stickers, arm
bracelets, and dedicated follow-up by the NP assigned to
each trauma team. No protocol was utilized for tracking
the nontrauma patients who had a filter inserted: these
patients were not followed in a dedicated manner. One
hundred sixty-seven retrievable filters were placed: 91 in
trauma patients and 76 in nontrauma patients. Trauma
patients were more likely to have their IVCF removed
than nontrauma patients: 55% versus 19%, P < .001.
There were differences between the three trauma teams,
with removal rates of 44%, 42%, and 86%, respectively (P
< .05). These investigators concluded that a policy of
dedicated follow-up of patients with IVCF can achieve
significantly higher rates of filter removal than have been
previously reported.
The authors found that the key to a successful
system was ‘‘identifying individuals who were responsi-
ble for the active outpatient follow-up of these patients,
with access to the resources necessary for retrieval
including duplex scanning, radiology scheduling, and
attending surgeons who would review indications for
removal in these patients.’’ (In other systems, clinically
oriented IR with knowledge of the SIR and ACCP
guidelines can also serve a similar role to that of the
attending surgeon.) As also stated in the report, the
investigators ‘‘chose to use nurse practitioners, who
provided continuity of care over the course of an entire
year, were able to successfully maintain a database of
these patients, and remain in contact with them to
arrange follow-up and outpatient studies.’’ It is note-
worthy that among the three NPs there were significant
differences in retrieval rate: 44%, 42%, and 86%. The
Figure 3 Brooke Army Medical Center Interventional Radiology business cards. In addition to various useful numbers listed
on the front of the card, the back has a reminder for filter patients. It emphasizes the importance of filter retrieval and provides a
cell phone number that can be answered after normal working hours to answer questions and arrange for follow-up
appointments.
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individual assigned to track filter patients may have other
competing responsibilities, and must be given the re-
sources necessary to be successful. Tracking trauma
patients can be time and labor intensive. In some
instances, having the time to achieve the task may be
the most important resource that responsible individual
will need. It also highlights the importance of identify-
ing dedicated personnel who are assigned to perform
close follow-up of filter patients.
Another excellent example of a successful tracking
and retrieval system can be found at University Medical
Center Brackenridge in Austin, Texas. In this level one
trauma center, the cardiology and IR services share a
series of catheterization suites (‘‘cath lab’’). There are two
registered nurses who work in the cath lab and have the
primary responsibility for ensuring that patients with
retrievable filters are tracked, and as many filters as
possible are removed when appropriate. These two
individuals consult with the primary care physician to
verify that the patients are on anticoagulation therapy
and are eligible for removal. The IR attendings are
consulted as needed.
Their successful process utilizes many helpful
adjuncts besides a database. As soon as a filter is placed,
the patient is scheduled for a filter repositioning or
retrieval within a designated timeframe. Following filter
Figure 4 Flow diagram of process to track and remove retrievable inferior vena cava (IVC) filters.
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insertion, an armband is placed to identify that the
patient has a retrievable filter. The medical record is
flagged with a sign placed on the front of the inpatient
chart. Finally, a sign is also placed on the door to the
patient’s room noting the presence of a filter patient. In
this manner, everyone involved in caring for this patient
is made aware of his or her status and the need for good
follow-up. Because of these efforts, this hospital is able
to follow-up and evaluate 98% of patients who have
received a retrievable filter, with 50% of all filters
eventually being removed—personal communication.
A business card with the name and means to
contact the individual designated to track all filter
patients should also be provided to both the patient
and any significant family member or friend. The tele-
phone number should be a direct line or even a cell
phone that can be answered after normal work hours.
This will greatly help to decrease loss to follow-up. At
Brooke Army Medical Center, Fort Sam Houston,
Texas, all patients in contact with the IR service are
given a business card. In addition to the phone and pager
numbers listed on the front, the business card has a back
section specifically designed for patients with retrievable
filters (Fig. 3). It emphasizes the importance of follow-
up, and clearly states how patients can contact the IR
service whenever there is a question or need to schedule
an appointment. This has proven to be an easy and
effective means by which patients, family members, and
health care providers are able to contact the IR service for
follow-up. This often translates to a successful retrieval
of a filter that may otherwise have not been done. The
business card is an inexpensive and effective adjunct that
should be utilized.
THE CHALLENGE
Many barriers currently exist that may make it difficult
to establish a successful tracking and retrieval system as
described above. A prophylactic IVCF is most often
inserted in the young multitrauma patient. It is well
known that trauma patients are often difficult to track
and are often lost to follow-up. Many of the trauma
patients are from inner-city, low-socioeconomic
groups and do not have a stable address or phone
number. Interestingly, in some clinical settings, the
most common reason for not retrieving a filter is
patient refusal. It has been noted by some IR that
many of the trauma patients do not want an additional
procedure to remove the IVCF if they are asympto-
matic. In other instances, patients undergo additional
procedures for years to correct orthopedic injuries, and
are worried about losing protection from a fatal PE if
they undergo filter retrieval. Despite these challenges,
every effort should be made to contact filter patients
and arrange follow-up. The expectations for a high
retrieval rate for all patients with IVCF should be
tempered with the reality that for the trauma popula-
tion it may not be as high as in other patient pop-
ulations. However, the young trauma patient stands to
gain the most whenever an IVCF that is no longer
needed is removed. Any operator inserting retrievable
filters has an obligation to ensure that there is a
tracking system in place to follow the patient. In the
event there is no such process currently in place, the
principles and resources discussed here will be helpful
in establishing such a system. An example of a simple
process is summarized in Fig. 4.
CONCLUSION
Retrievable and prophylactic IVC filters should be
placed based on currently accepted indications that are
discussed in the guidelines from SIR and ACCP. The
protective effect of filters is offset by the potential for
DVT, IVC thrombosis, possible otherwise unnecessary
lifelong AC, and filter migration or fracture. The stand-
ard duration of treatment for many VTE is 3 to 6 months
of AC/filter. Filters should be retrieved as soon as the
risk for a PE warrants their removal. This occurs when
the duration of treatment for a DVT/PE has been met,
the risk of a PE is no longer high, and/or there is no
longer a contraindication to AC. An effective system
that leads to improving the retrieval rate of an IVCF
must include thorough education of the patient and the
family, an accurate tracking system to minimize patient
lost to follow-up, and dedicated personnel responsible
for overseeing the entire process. If these goals are
accomplished, interventionalists can help decrease the
incidence of a fatal PE during the high-risk period,
decrease the risk of a DVT, and the use of otherwise
unnecessary lifelong AC in subsequent years. Currently,
there is much room for improvement in the frequency
that IVCF patients are systematically followed and filters
are retrieved. The very informative and useful 2006 SIR
guidelines for the use of retrievable IVCF should be
implemented now. The principles discussed in this
report will be helpful in this process.
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